| 000 | 01611 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517135609.0 | ||
| 264 | 0 | _c20171108 | |
| 008 | 201711s 0 0 eng d | ||
| 022 | _a2152-2669 | ||
| 024 | 7 |
_a10.1016/j.clml.2016.11.006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDhakal, Binod | |
| 245 | 0 | 0 |
_aAutologous Hematopoietic Cell Transplantation in Patients With Multiple Myeloma: Effect of Age. _h[electronic resource] |
| 260 |
_bClinical lymphoma, myeloma & leukemia _c03 2017 |
||
| 300 |
_a165-172 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xmortality |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelphalan _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aTransplantation Conditioning _xmortality |
| 650 | 0 | 4 |
_aTransplantation, Autologous _xmortality |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aNelson, Ariel | |
| 700 | 1 | _aGuru Murthy, Guru Subramanian | |
| 700 | 1 | _aFraser, Raphael | |
| 700 | 1 | _aEastwood, Daniel | |
| 700 | 1 | _aHamadani, Mehdi | |
| 700 | 1 | _aPasquini, Marcello | |
| 700 | 1 | _aD'Souza, Anita | |
| 700 | 1 | _aHari, Parameswaran | |
| 773 | 0 |
_tClinical lymphoma, myeloma & leukemia _gvol. 17 _gno. 3 _gp. 165-172 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clml.2016.11.006 _zAvailable from publisher's website |
| 999 |
_c26848746 _d26848746 |
||